EC Number |
Inhibitors |
Structure |
---|
3.6.5.5 | (2-chloro-6-methylpyrimidin-4-yl)tetradecylamine |
- |
|
3.6.5.5 | (2E)-2-cyano-N-(3-[[(2E)-2-cyano-3-(3,4-dimethoxyphenyl)prop-2-enoyl]amino]propyl)-3-(3,4-dihydroxyphenyl)prop-2-enamide |
- |
|
3.6.5.5 | (2E)-2-cyano-N-(3-[[(2E)-2-cyano-3-(4-hydroxyphenyl)prop-2-enoyl]amino]propyl)-3-(3,4-dihydroxyphenyl)prop-2-enamide |
- |
|
3.6.5.5 | (2E)-2-cyano-N-(3-[[(2E)-2-cyano-3-phenylprop-2-enoyl]amino]propyl)-3-(3,4-dihydroxyphenyl)prop-2-enamide |
- |
|
3.6.5.5 | (2E,2'E)-N,N'-(2-hydroxypropane-1,3-diyl)bis[2-cyano-3-(3,4-dihydroxyphenyl)prop-2-enamide] |
- |
|
3.6.5.5 | (2E,2'E)-N,N'-(2-phenoxypropane-1,3-diyl)bis[2-cyano-3-(3,4-dihydroxyphenyl)prop-2-enamide] |
- |
|
3.6.5.5 | (2E,2'E)-N,N'-(2-propoxypropane-1,3-diyl)bis[2-cyano-3-(3,4-dihydroxyphenyl)prop-2-enamide] |
- |
|
3.6.5.5 | (3S-trans)-3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-piperidine |
paroxetine |
|
3.6.5.5 | (4-chloro-6-methylpyrimidin-2-yl)(1-cyclopropylmethylpropyl)amine |
- |
|
3.6.5.5 | (4-chloro-6-methylpyrimidin-2-yl)-dimethylamine |
- |
|